[9-5-2025] The Food and Drug Administration is advising consumers not to purchase or use FTX PLUS, a product promoted and sold for joint pain on various websites, including walmart.com and possibly in some retail stores. FDA laboratory analysis confirmed …
[9-5-2025] The Food and Drug Administration is advising consumers not to purchase or use REUMA KING, a product promoted and sold for joint pain on various websites, including ebay.com and possibly in some retail stores. FDA laboratory analysis confirmed …
Image Español People seeking to treat their ailments sometimes mistake a product as being safe because it’s easily available, whether online or even at gas stations. But availability is no indication of effectiveness or safety. This is especially true of …
For Immediate Release: May 09, 2025 The U.S. Food and Drug Administration today announced it granted three new color additive petitions that will expand the palette of available colors from natural sources for manufacturers to safely use in food. The FDA …
For Immediate Release: September 05, 2025 The U.S. Food and Drug Administration today established a “green list” import alert to help stop potentially dangerous GLP-1 (glucagon-like peptide-1) active pharmaceutical ingredients (APIs) from unverified …
HOW TO USE THIS SNAPSHOT The information provided in Snapshots highlights who participated in the key clinical trials that supported the original FDA approval of this drug, and whether there were differences among sex, race, age, and ethnic groups. The “ …
COMPANY ANNOUNCEMENT When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company. Read Announcement View Product Photos …
On This Page Date: June 3 - 4, 2025 Day1: Tue, Jun 03 8:00 a.m. - 05:30 p.m. ET Day2: Wed, Jun 04 9:00 a.m. - 04:30 p.m. ET Join Event (June 3-4, 2025) Location The workshop will be hosted as a hybrid (in-person and virtual) meeting. Attendees may join in …
Date: May 20 - 21, 2025 Day1: Tue, May 20 8:00 a.m. - 05:00 p.m. ET Day2: Wed, May 21 8:00 a.m. - 05:00 p.m. ET What is an advisory committee? Advisory committees provide independent expert advice to the FDA on broad scientific topics or on certain …
On May 8, 2025, the Food and Drug Administration granted accelerated approval to the combination of avutometinib and defactinib (Avmapki Fakzynja Co-pack, Verastem, Inc.) for adult patients with KRAS-mutated recurrent low-grade serous ovarian cancer (LGSOC …
COMPANY ANNOUNCEMENT When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company. Read Announcement View Product Photos …
For Immediate Release: May 08, 2025 In a historic first for the agency, FDA Commissioner Martin A. Makary, M.D., M.P.H., today announced an aggressive timeline to scale use of artificial intelligence (AI) internally across all FDA centers by June 30, 2025, …
On This Page Date: August 27 - 28, 2025 Day1: Wed, Aug 27 10:00 a.m. - 01:00 p.m. ET Day2: Thu, Aug 28 10:00 a.m. - 01:00 p.m. ET Image Background The U.S. Food and Drug Administration (FDA) Oncology Center of Excellence (OCE) will host a two-day virtual …
Delivery Method: Via Email Reference #: 320-25-93 Product: Drugs Recipient: Recipient Name Mr. Norman Craig Delgado Recipient Title President and CEO Oasis Medical, Inc. 514 S. Vermont Avenue Glendora, CA 91741 United States Issuing Office: Center for Drug …
Advisory Committee Meeting | Virtual Scheduled On This Page Date: May 22, 2025 Time: 8:30 a.m. - 4:30 p.m. ET What is an advisory committee? Advisory committees provide independent expert advice to the FDA on broad scientific topics or on certain products …
On This Page Visit CDER Small Business and Industry Assistance (SBIA) Homepage About this Event (Hosted by CDER SBIA) At the end of this two-part webinar, participants will understand the purpose of a Certificate of Confidentiality (CoC), be able to …
Summary Company Announcement Date: May 07, 2025 FDA Publish Date: May 07, 2025 Product Type: Cosmetics Reason for Announcement: Recall Reason Description Tattoo inks that are contaminated with bacteria, including Pseudomonas aeruginosa. Company Name: U.S. …
As announced in the Federal Register Notice on June 11, 2024, CDER has established a program called the Emerging Drug Safety Technology Program, which will administer Emerging Drug Safety Technology Meetings (EDSTM). The program provides applicants with an …
COMPANY ANNOUNCEMENT When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company. Read Announcement View Product Photos …
COMPANY ANNOUNCEMENT When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company. Read Announcement View Product Photos …
06 days 14:25:10
